PMID: 2098122Dec 1, 1990Paper

Antimicrobial resistance of Haemophilus influenzae isolated outside of the hospital

Enfermedades infecciosas y microbiología clínica
B Orden, M A Amérigo

Abstract

A total of 209 H. influenzae strains isolated from follow-up patients were studied. Twenty eight strains were serotype b (13.4%), 82 corresponded to type I of Kilian (39.2%), and 41 produced beta-lactamase (19.6%). Strains were resistant to trimethoprim-sulfamethoxazole (SXT) in 79.9% of cases, to the erythromycin in 18.2%, to tetracycline in 16.7%, to chloramphenicol in 13.8%, and to cefaclor in 0.1% of instances. There were no strains resistant to cefotaxime nor to amoxicillin/clavulanic acid. Resistances to three or more antibiotics were observed in 14.8% of the strains. The most common of these combinations was ampicillin-chloramphenicol-tetracycline SXT (61.3%).

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
P SantanamF H Kayser
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
C HeneyH J Koornhof
© 2021 Meta ULC. All rights reserved